Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration

Analytical and Bioanalytical Chemistry

Volumn 401, Issue 2, 2011, Pages 599-607

  Milman, Garry ^a   Barnes, Allan J ^a   Schwope, David M ^b   Schwilke, Eugene W ^a   Goodwin, Robert S ^a   Kelly, Deana L ^c   Gorelick, David A ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b AIT Laboratories   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

9 tetrahydrocannabinol; Cannabinoids; Dronabinol; Expectoration; Oral fluid

Indexed keywords

ANALYTES; CANNABINOIDS; CANNABINOL; DRIVING UNDER THE INFLUENCE; DRONABINOL; DRUG TESTING; ELECTRON-IMPACT IONIZATION; EXPECTORATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LINEAR RANGE; MATRIX; MENTAL HEALTH SERVICES; NEGATIVE CHEMICAL IONIZATION; ORAL FLUID; ORAL FLUIDS; SUBSTANCE ABUSE;

CHEMICAL ANALYSIS; FLUIDS; GAS CHROMATOGRAPHY; IONIZATION OF GASES; MASS SPECTROMETRY; MONITORING; POLLUTION DETECTION; TESTING;

IMPACT IONIZATION;

11 NOR DELTA(9) TETRAHYDROCANNABINOL 9 CARBOXYLIC ACID; 11-NOR-DELTA(9)-TETRAHYDROCANNABINOL-9-CARBOXYLIC ACID; DRUG DERIVATIVE; TETRAHYDROCANNABINOL;

ADOLESCENT; ADULT; ARTICLE; BODY FLUID; CANNABIS ADDICTION; CANNABIS SMOKING; CHEMISTRY; HUMAN; MASS FRAGMENTOGRAPHY; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUTH; ORAL DRUG ADMINISTRATION; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; TIME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BODY FLUIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; MIDDLE AGED; MOUTH; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL; TIME FACTORS; YOUNG ADULT;

CANNABIS;

EID: 79960555913     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-011-5066-4     Document Type: Article

References (27)

1. DM Ledgerwood BA Goldberger NK Risk CE Lewis RK Price 2008 Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged men Addict Behav 33 9 1131 1139 10.1016/j.addbeh.2008.04.009
2. F Musshoff F Driever K Lachenmeier DW Lachenmeier M Banger B Madea 2006 Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests Forensic Sci Int 156 2-3 118 123 10.1016/j.forsciint.2004.07.024 1:CAS:528:DC%2BD28XksFClsg%3D%3D (Pubitemid 43061252)
3. I Kim AJ Barnes JM Oyler R Schepers RE Joseph Jr EJ Cone D Lafko ET Moolchan MA Huestis 2002 Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration Clin Chem 48 1486 1496 1:CAS:528:DC%2BD38XmslSqtbc%3D (Pubitemid 34925783)
4. DJ Crouch 2005 Oral fluid collection: the neglected variable in oral fluid testing Forensic Sci Int 150 2-3 165 173 10.1016/j.forsciint.2005.02.028 1:CAS:528:DC%2BD2MXltFejs7g%3D (Pubitemid 41583219)
5. N Samyn C van Haeren 2000 On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users Int J Leg Med 113 150 154 10.1007/s004140050287 1:STN:280:DC%2BD3cvotVGhtg%3D%3D (Pubitemid 30339652)
6. E Kaufman IB Lamster 2002 The diagnostic applications of saliva-a review Crit Rev Oral Biol Med 13 2 197 212 10.1177/154411130201300209
7. WM Bosker MA Huestis 2009 Oral fluid testing for drugs of abuse Clin Chem 55 11 1910 1931 10.1373/clinchem.2008.108670 1:CAS:528:DC%2BD1MXhsVSkurbF
8. C Moore W Ross C Coulter L Adams S Rana M Vincent J Soares 2006 Detection of the marijuana metabolite 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays J Anal Toxicol 30 7 413 418 1:CAS:528:DC%2BD28XoslGlt7g%3D (Pubitemid 44371481)
9. GF Kauert S Iwersen-Bergmann SW Toennes 2006 Assay of delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device J Anal Toxicol 30 4 274 277 1:CAS:528: DC%2BD28XjvFGgs70%3D (Pubitemid 44285269)
10. M Haney AS Ward SD Comer RW Foltin MW Fischman 1999 Abstinence symptoms following oral THC administration to humans Psychopharmacol 141 385 394 10.1007/s002130050848 1:CAS:528:DyaK1MXhtlyitb0%3D (Pubitemid 29190007)
11. Food and Drug Administration (2004) MARINOL® (Dronabinol) Capsules. 500012 Rev Sep 2004 ed
12. G Milman AJ Barnes RH Lowe MA Huestis 2010 Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry J Chromatogr A 1217 1513 1521 10.1016/j.chroma.2009.12.053 1:CAS:528:DC%2BC3cXhslWmsbs%3D
13. N Enberg H Alho V Loimaranta M Lenander-Lumikari 2001 Saliva flow rate, amylase activity, and protein and electrolyte concentrations in saliva after acute alcohol consumption Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 3 292 298 10.1067/moe.2001.116814 1:STN:280:DC%2BD3Mrgtlaktg%3D%3D (Pubitemid 33608870)
14. PDV de Almeida AMT Grégio MÂN Machado AAS de Lima LR Azevedo 2008 Saliva composition and functions: a comprehensive review J Contemp Dent Pract 9 3 72 80
15. P Kintz N Samyn 2002 Use of alternative specimens: drugs of abuse in saliva and doping agents in hair Ther Drug Monit 24 239 246 10.1097/00007691- 200204000-00006 1:CAS:528:DC%2BD38XivVyjur4%3D (Pubitemid 34246553)
16. KM Hold D De Boer J Zuidema RAA Maes 1996 Saliva as an analytical tool in toxicology Int J Drug Test 1 1 31
17. P Lillsunde 2008 Analytical techniques for drug detection in oral fluid Ther Drug Monit 30 2 181 187 10.1097/FTD.0b013e3181685088 1:CAS:528: DC%2BD1cXjslSqtb0%3D (Pubitemid 351521645)
18. H Teixeira P Proenca A Verstraete F Corte-Real DN Vieira 2005 Analysis of delta-9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry Forensic Sci Int 150 2-3 205 211 10.1016/j.forsciint.2004.11.026 1:CAS:528:DC%2BD2MXltFejsL4%3D (Pubitemid 41583224)
19. G Milman AJ Barnes DM Schwope EW Schwilke WD Darwin RS Goodwin DL Kelly DA Gorelick MA Huestis 2010 Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration Clin Chem 56 8 1261 1269 10.1373/clinchem.2009.141853 1:CAS:528:DC%2BC3cXhtVahsb7N
20. GF Kauert JG Ramaekers E Schneider MR Moeller SW Toennes 2007 Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid J Anal Toxicol 31 5 288 293 1:CAS:528:DC%2BD2sXmt1GmsL4%3D (Pubitemid 46911627)
21. RS Niedbala KW Kardos DF Fritch S Kardos T Fries J Waga J Robb EJ Cone 2001 Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana J Anal Toxicol 25 5 289 303 1:CAS:528:DC%2BD3MXlsFalsr4%3D (Pubitemid 32656280)
22. DHHS 2004 Proposed revisions to mandatory guidelines for federal workplace drug testing programs Fed Regist 69 71 19673 19732
23. K Pil E Raes AG Verstraete 2009 The toxicological challenges in the European research project DRUID Forensic Sci Int Suppl Ser 1 1 29 32 10.1016/j.fsisup.2009.08.001
24. E Karschner E Schwilke R Lowe W Darwin H Pope Jr R Herning J Cadet M Huestis 2009 Do delta 9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction 104 2041 2048 10.1111/j.1360-0443.2009. 02705.x
25. E Karschner E Schwilke R Lowe WD Darwin R Herning J Cadet M Huestis 2009 Implications of plasma delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers J Anal Toxicol 33 8 469 477 1:CAS:528:DC%2BD1MXht1yntbbK
26. ME Wall BM Sadler D Brine H Taylor M Perez-Reyes 1983 Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women Clin Pharmacol Ther 34 352 363 10.1038/clpt.1983.179 1:CAS:528:DyaL3sXlvVOjsbg%3D (Pubitemid 13006304)
27. C Moore S Rana C Coulter 2007 Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid J Chromatogr B Anal Technol Biomed Life Sci 852 1-2 459 464 10.1016/j.jchromb.2007.02.016 1:CAS:528:DC%2BD2sXmtVGmuro%3D (Pubitemid 46830152)